Compared to the FFWO assay, resistance of the double mutant virus to the inhibitory effect in the cell-cell fusion assay was not observed at the highest concentrations tested likely due to methodological differences between approaches based on infection with replicative viruses and overexpression of envelope proteins, respectively. This evidence concerns the gene ERVW-1 and infection.